Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edgewise Therapeutics (EWTX) Cash from Operations (2020 - 2026)

Edgewise Therapeutics has reported Cash from Operations over the past 7 years, most recently at 42543000.0 for Q1 2026.

  • Quarterly results put Cash from Operations at 42543000.0 for Q1 2026, down 12.35% from a year ago — trailing twelve months through Mar 2026 was 148493000.0 (down 25.53% YoY), and the annual figure for FY2025 was 143816000.0, down 31.91%.
  • Cash from Operations reached 42543000.0 in Q1 2026 per EWTX's latest filing, down from 38592000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 11855000.0 in Q4 2022 and bottomed at 42543000.0 in Q1 2026.
  • Median Cash from Operations over the past 5 years was 26830000.0 (2023), compared with a mean of 25880588.24.
  • The largest annual shift saw Cash from Operations tumbled 126.32% in 2023 before it decreased 0.47% in 2024.
  • Over 5 years, Cash from Operations stood at 11855000.0 in 2022, then crashed by 126.32% to 26830000.0 in 2023, then dropped by 0.47% to 26957000.0 in 2024, then tumbled by 43.16% to 38592000.0 in 2025, then decreased by 10.24% to 42543000.0 in 2026.
  • Business Quant data shows Cash from Operations for EWTX at 42543000.0 in Q1 2026, 38592000.0 in Q4 2025, and 34776000.0 in Q3 2025.